Insights

RNA-based expansion Opportunity to package and upsell RNA-based crop protection solutions to growers and agribusiness partners as GreenLight scales production in Brazil and Mexico, aligning with their RNAi focus and recent launches like Norroa.

Global manufacturing footprint Leverage GreenLight’s planned multi‑facility investments in Mexico and expansion in Brazil to position our equipment, supply chain services, or contract manufacturing capabilities as a fit for their increasing local production needs.

Public-benefit positioning Align offerings with GreenLight’s mission-driven, environmental priorities by presenting sustainability‑aligned services, certification support, and lifecycle analysis to attract partners in agricultural retail, cooperatives, and food producers seeking eco-friendly solutions.

Bee health focus Capitalize on Norroa’s market traction for varroa mite control by offering integrated pollinator‑friendly product ecosystems, field analytics, and regulatory support packages to beekeeping associations, farmers, and distributors.

Data and analytics leverage Propose data and analytics partnerships using their tech stack (Power BI, Tableau) to monitor field performance, yield impacts, and environmental benefits, enabling evidence-based sales pitches to large farming networks and government programs.

Similar companies to GreenLight Biosciences

GreenLight Biosciences Tech Stack

GreenLight Biosciences uses 8 technology products and services including Power BI, Tableau, Squarespace, and more. Explore GreenLight Biosciences's tech stack below.

Media & News

GreenLight Biosciences's Email Address Formats

GreenLight Biosciences uses at least 9 email formats:
GreenLight Biosciences Email FormatsExamplePercentage
FLast@greenlightbio.comJDoe@greenlightbio.com
67%
Last@greenlightbio.comDoe@greenlightbio.com
20%
First.Last@greenlightbio.comJohn.Doe@greenlightbio.com
11%
FMLast@greenlightbio.comJMDoe@greenlightbio.com
2%
FLast@glbiosciences.comJDoe@glbiosciences.com
74%
First.Last@glbiosciences.comJohn.Doe@glbiosciences.com
24%
FMLast@glbiosciences.comJMDoe@glbiosciences.com
1%
FirstLast@glbiosciences.comJohnDoe@glbiosciences.com
1%
FirstL@greenlightbiosciences.comJohnD@greenlightbiosciences.com
100%

Frequently Asked Questions

What is GreenLight Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact GreenLight Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is GreenLight Biosciences's stock symbol?

Minus sign iconPlus sign icon
GreenLight Biosciences is a publicly traded company; the company's stock symbol is GRNA.

What is GreenLight Biosciences's official website and social media links?

Minus sign iconPlus sign icon
GreenLight Biosciences's official website is greenlightbiosciences.com and has social profiles on LinkedIn.

How much revenue does GreenLight Biosciences generate?

Minus sign iconPlus sign icon
As of October 2026, GreenLight Biosciences's annual revenue is estimated to be $50M - $100M.

What is GreenLight Biosciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
GreenLight Biosciences's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does GreenLight Biosciences have currently?

Minus sign iconPlus sign icon
As of October 2026, GreenLight Biosciences has approximately 174 employees across 4 continents, including North America, South America and Europe. Key team members include Chief Commercial Officer: S. V. T., Vice President - Ops And Strategy: I. F. and Vice President Of Research And Development: W. B. Explore GreenLight Biosciences's employee directory with LeadIQ.

What industry does GreenLight Biosciences belong to?

Minus sign iconPlus sign icon
GreenLight Biosciences operates in the Biotechnology Research industry.

What technology does GreenLight Biosciences use?

Minus sign iconPlus sign icon
GreenLight Biosciences's tech stack includes Power BI, Tableau, Squarespace, PostgreSQL, Webflow, Smartsheet, Microsoft Teams and Zoom.

What is GreenLight Biosciences's email format?

Minus sign iconPlus sign icon
GreenLight Biosciences's email format typically follows the pattern of FLast@greenlightbio.com. Find more GreenLight Biosciences email formats with LeadIQ.

When was GreenLight Biosciences founded?

Minus sign iconPlus sign icon
GreenLight Biosciences was founded in 2008.
GreenLight Biosciences logo

GreenLight Biosciences

Biotechnology ResearchMassachusetts, United States51-200 Employees

GreenLight Biosciences is a biotechnology research company headquartered at 200 Boston Avenue, Suite 3100, Medford, Massachusetts, employing 51-200 people. It operates as a mission-driven public-benefit corporation focused on crop protection for farmers, seeking to develop environmentally friendly, effective, and easy-to-use solutions by leveraging natural approaches. The company has announced Norroa, described as the first RNA-based treatment for varroa mites, and has reported EPA registration for Norroa. GreenLight has pursued international expansion, with manufacturing growth in Rochester and office expansion across Europe, including the United Kingdom. It has engaged in external financing to support growth, including a Series C funding round and loans from institutions such as the European Investment Bank.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
GRNA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $50M - $100M

    GreenLight Biosciences's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.